GLP-1 Therapy Medical Weight Loss Program Lake Forest, Illinois A personalized medical program designed to support appetite control and long-term weight loss
Cultural narratives about willpower, personal responsibility, and moral failure in obesity create receptivity to messages that frame medication as cheating, addiction, or dangerous shortcuts
That's not a misprint - it's a new federal program that went live July 1, 2026
How patients can get GLP-1 medications Accessing GLP-1 medications usually begins with a visit to a primary care provider or endocrinologist
Key Takeaways Nausea is a common adverse effect of retatrutide and other GLP-1s because of their action on gastric motility and gut hormones

UK only [edit] Capsules Episenta prolonged release by Beacon Sachets Episenta prolonged release by Beacon Intravenous solution for injection Episenta solution for injection by Beacon Germany, Switzerland, Norway, Finland, Sweden [edit] Tablets Orfiril by Desitin Pharmaceuticals Intravenous injection Orfiril IV by Desitin Pharmaceuticals South Africa [edit] Syrup Convulex by Byk Madaus [140] Tablets Epilim by Sanofi-synthelabo Malaysia [edit] Tablets Epilim ( 200 ENTERIC COATED ) by Sanofi-Aventis Controlled release tablets Epilim Chrono ( 500 CONTROLLED RELEASE ) by Sanofi-Aventis [141] Romania [edit] Companies are SANOFI-AVENTIS FRANCE, GEROT PHARMAZEUTIKA GMBH and DESITIN ARZNEIMITTEL GMBH Types are Syrup, Extended release mini tablets, Gastric resistant coated tablets, Gastric resistant soft capsules, Extended release capsules, Extended release tablets and Extended release coated tablets Canada [edit] Intravenous injection Epival or Epiject by Abbott Laboratories